High glycemic index tracks with markedly higher multiple myeloma odds
A new case-control analysis from Iran links a diet with a high glycemic index to substantially greater odds of multiple myeloma, adding to a long-running debate over whether carbohydrate quality influences plasma cell cancer risk. The signal was not subtle: people in the highest quartile of dietary GI had nearly four times the odds of MM compared with those in the lowest quartile after full adjustment for measured confounders.
The study enrolled 141 newly diagnosed MM patients and 348 healthy controls, all between 20 and 75 years of age. Dietary intake came from a validated 154-item semi-quantitative food frequency questionnaire, and investigators derived both GI and glycemic load from reported food consumption. Binary logistic regression then examined quartiles of exposure while accounting for age, sex, total energy intake, and other lifestyle factors.
One finding stood out immediately. Glycemic load lost its association with MM once energy intake and other covariates were included.
Why carbohydrate quality may matter more than carbohydrate quantity
GI captures how quickly a carbohydrate-containing food raises postprandial glucose, while GL blends that quality measure with the amount consumed. In practical terms, GI may better reflect repeated spikes in glucose and insulin signaling than GL alone, especially when total energy intake varies widely across individuals. That distinction is biologically important in a malignancy such as MM, where insulin resistance, chronic low-grade inflammation, and altered growth signaling can shape the marrow environment in ways that favor clonal plasma cell expansion.
The fully adjusted odds ratio for the highest versus lowest GI quartile was 3.92, with a 95% confidence interval of 1.84 to 8.34 and a trend P value below 0.001. The magnitude of that association is striking, but it should be read in the context of a case-control design. Such studies can identify correlations and generate hypotheses; they cannot prove that a high-GI diet caused the cancer to develop.
Even so, the pattern is coherent with established metabolic biology. Repeated surges in glucose and insulin can amplify insulin-like growth factor signaling, alter adipokine profiles, and promote pro-inflammatory states that may support malignant cell survival. In a disease like MM, where the bone marrow niche already favors survival of abnormal plasma cells, those upstream metabolic pressures could plausibly contribute to a more permissive environment.
The glycemic load signal faded after adjustment
GL appeared inversely related to MM in crude analysis, but that relationship disappeared after adjustment for energy intake. In the fully adjusted model, GL was not associated with MM, with an odds ratio of 1.37, a 95% confidence interval of 0.51 to 3.63, and a P trend of 0.45. This divergence between GI and GL suggests that the quality of carbohydrate intake may be more relevant than the total glycemic burden once overall calorie intake is taken into account.
That result also argues against overinterpreting a single dietary composite score. GL can be influenced by portion size, eating patterns, and total caloric intake, all of which may obscure the effect of rapidly absorbed carbohydrates. GI, by isolating the blood glucose response of the foods themselves, may have captured the biologically relevant signal more cleanly in this dataset.
What the study can and cannot say
The cohort was drawn from an Iranian population, and the findings may not generalize automatically to other dietary patterns or cancer epidemiology settings. Case-control studies also depend on recalled diet, which introduces the possibility of measurement error and recall bias, even when a validated questionnaire is used. Residual confounding remains possible despite multivariable adjustment, especially for unmeasured factors that can cluster with diet, body composition, physical activity, and metabolic health.
Still, the signal is hard to dismiss. A near fourfold difference in odds across GI quartiles, paired with a null GL result after adjustment, points toward carbohydrate quality as a candidate exposure worth testing in larger prospective cohorts. It would be a mistake to treat that association as a directive for MM prevention today, but it is strong enough to influence the next round of epidemiologic work.
Bedside implications remain cautious but clinically relevant
For clinicians counseling patients about cancer risk reduction, the study adds one more reason to emphasize food choices that blunt rapid postprandial glucose excursions. Whole grains, legumes, minimally processed vegetables, and other lower-GI foods may be preferable to refined starches and highly processed carbohydrate sources, not because this study proves prevention, but because the metabolic rationale is plausible and the broader cardiometabolic benefits are well established.
Multiple myeloma rarely arises from a single dietary exposure. Its pathogenesis reflects a long interaction among age, host biology, immune signaling, and environmental pressures. Diet may sit one step upstream of those processes, shaping insulin resistance and inflammation before the marrow microenvironment ever becomes clinically visible.
The study was funded by Shahid Beheshti University of Medical Sciences, and the investigators reported no competing interests. Ethics approval was obtained from the institutional committee, and all participants gave written informed consent. Future prospective studies will need to determine whether the GI association persists after repeated dietary measurement, stronger control of metabolic confounding, and follow-up long enough to capture incident MM rather than retrospective recall of prediagnostic intake.